Merit Medical's stock plummeted 5.00% during intraday trading on Wednesday, marking a significant decline for the medical device company.
The sharp drop appears to be driven by analyst actions, particularly Needham's decision to cut its price target on Merit Medical Systems from $108 to $101 while maintaining a Buy rating. This reduction in price target suggests analysts have tempered their expectations for the company's future performance, which may have prompted investor selling pressure.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.